BACKGROUND: Truncating variants in the Titin gene (TTNtvs) are common in individuals with idiopathic dilated cardiomyopathy (DCM). However, a comprehensive genomics-first evaluation of the impact of TTNtvs in different clinical contexts, and the evaluation of modifiers such as genetic ancestry, has not been performed. METHODS: We reviewed whole exome sequence data for >71 000 individuals (61 040 from the Geisinger MyCode Community Health Initiative (2007 to present) and 10 273 from the PennMedicine BioBank (2013 to present) to identify anyone with TTNtvs. We further selected individuals with TTNtvs in exons highly expressed in the heart (proportion spliced in [PSI] >0.9). Using linked electronic health records, we evaluated associations of TTNtvs with diagnoses and quantitative echocardiographic measures, including subanalyses for individuals with and without DCM diagnoses. We also reviewed data from the Jackson Heart Study to validate specific analyses for individuals of African ancestry. RESULTS: Identified with a TTNtv in a highly expressed exon (hiPSI) were 1.2% individuals in PennMedicine BioBank and 0.6% at Geisinger. The presence of a hiPSI TTNtv was associated with increased odds of DCM in individuals of European ancestry (odds ratio [95% CI]: 18.7 [9.1-39.4] {PennMedicine BioBank} and 10.8 [7.0-16.0] {Geisinger}). hiPSI TTNtvs were not associated with DCM in individuals of African ancestry, despite a high DCM prevalence (odds ratio, 1.8 [0.2-13.7]; P=0.57). Among 244 individuals of European ancestry with DCM in PennMedicine BioBank, hiPSI TTNtv carriers had lower left ventricular ejection fraction (β=-12%, P=3×10-7), and increased left ventricular diameter (β=0.65 cm, P=9×10-3). In the Geisinger cohort, hiPSI TTNtv carriers without a cardiomyopathy diagnosis had more atrial fibrillation (odds ratio, 2.4 [1.6-3.6]) and heart failure (odds ratio, 3.8 [2.4-6.0]), and lower left ventricular ejection fraction (β=-3.4%, P=1×10-7). CONCLUSIONS: Individuals of European ancestry with hiPSI TTNtv have an abnormal cardiac phenotype characterized by lower left ventricular ejection fraction, irrespective of the clinical manifestation of cardiomyopathy. Associations with arrhythmias, including atrial fibrillation, were observed even when controlling for cardiomyopathy diagnosis. In contrast, no association between hiPSI TTNtvs and DCM was discerned among individuals of African ancestry. Given these findings, clinical identification of hiPSI TTNtv carriers may alter clinical management strategies.
BACKGROUND: Truncating variants in the Titin gene (TTNtvs) are common in individuals with idiopathic dilated cardiomyopathy (DCM). However, a comprehensive genomics-first evaluation of the impact of TTNtvs in different clinical contexts, and the evaluation of modifiers such as genetic ancestry, has not been performed. METHODS: We reviewed whole exome sequence data for >71 000 individuals (61 040 from the Geisinger MyCode Community Health Initiative (2007 to present) and 10 273 from the PennMedicine BioBank (2013 to present) to identify anyone with TTNtvs. We further selected individuals with TTNtvs in exons highly expressed in the heart (proportion spliced in [PSI] >0.9). Using linked electronic health records, we evaluated associations of TTNtvs with diagnoses and quantitative echocardiographic measures, including subanalyses for individuals with and without DCM diagnoses. We also reviewed data from the Jackson Heart Study to validate specific analyses for individuals of African ancestry. RESULTS: Identified with a TTNtv in a highly expressed exon (hiPSI) were 1.2% individuals in PennMedicine BioBank and 0.6% at Geisinger. The presence of a hiPSI TTNtv was associated with increased odds of DCM in individuals of European ancestry (odds ratio [95% CI]: 18.7 [9.1-39.4] {PennMedicine BioBank} and 10.8 [7.0-16.0] {Geisinger}). hiPSI TTNtvs were not associated with DCM in individuals of African ancestry, despite a high DCM prevalence (odds ratio, 1.8 [0.2-13.7]; P=0.57). Among 244 individuals of European ancestry with DCM in PennMedicine BioBank, hiPSI TTNtv carriers had lower left ventricular ejection fraction (β=-12%, P=3×10-7), and increased left ventricular diameter (β=0.65 cm, P=9×10-3). In the Geisinger cohort, hiPSI TTNtv carriers without a cardiomyopathy diagnosis had more atrial fibrillation (odds ratio, 2.4 [1.6-3.6]) and heart failure (odds ratio, 3.8 [2.4-6.0]), and lower left ventricular ejection fraction (β=-3.4%, P=1×10-7). CONCLUSIONS: Individuals of European ancestry with hiPSI TTNtv have an abnormal cardiac phenotype characterized by lower left ventricular ejection fraction, irrespective of the clinical manifestation of cardiomyopathy. Associations with arrhythmias, including atrial fibrillation, were observed even when controlling for cardiomyopathy diagnosis. In contrast, no association between hiPSI TTNtvs and DCM was discerned among individuals of African ancestry. Given these findings, clinical identification of hiPSI TTNtv carriers may alter clinical management strategies.
Entities:
Keywords:
cardiomyopathy, dilated; connectin; continental population groups; genetic association studies; genetics
Authors: Joshua C Denny; Marylyn D Ritchie; Melissa A Basford; Jill M Pulley; Lisa Bastarache; Kristin Brown-Gentry; Deede Wang; Dan R Masys; Dan M Roden; Dana C Crawford Journal: Bioinformatics Date: 2010-03-24 Impact factor: 6.937
Authors: Jan Haas; Karen S Frese; Barbara Peil; Wanda Kloos; Andreas Keller; Rouven Nietsch; Zhu Feng; Sabine Müller; Elham Kayvanpour; Britta Vogel; Farbod Sedaghat-Hamedani; Wei-Keat Lim; Xiaohong Zhao; Dmitriy Fradkin; Doreen Köhler; Simon Fischer; Jennifer Franke; Sabine Marquart; Ioana Barb; Daniel Tian Li; Ali Amr; Philipp Ehlermann; Derliz Mereles; Tanja Weis; Sarah Hassel; Andreas Kremer; Vanessa King; Emil Wirsz; Richard Isnard; Michel Komajda; Alessandra Serio; Maurizia Grasso; Petros Syrris; Eleanor Wicks; Vincent Plagnol; Luis Lopes; Tenna Gadgaard; Hans Eiskjær; Mads Jørgensen; Diego Garcia-Giustiniani; Martin Ortiz-Genga; Maria G Crespo-Leiro; Rondal H Lekanne Dit Deprez; Imke Christiaans; Ingrid A van Rijsingen; Arthur A Wilde; Anders Waldenstrom; Martino Bolognesi; Riccardo Bellazzi; Stellan Mörner; Justo Lorenzo Bermejo; Lorenzo Monserrat; Eric Villard; Jens Mogensen; Yigal M Pinto; Philippe Charron; Perry Elliott; Eloisa Arbustini; Hugo A Katus; Benjamin Meder Journal: Eur Heart J Date: 2014-08-27 Impact factor: 29.983
Authors: Angharad M Roberts; James S Ware; Daniel S Herman; Sebastian Schafer; John Baksi; Alexander G Bick; Rachel J Buchan; Roddy Walsh; Shibu John; Samuel Wilkinson; Francesco Mazzarotto; Leanne E Felkin; Sungsam Gong; Jacqueline A L MacArthur; Fiona Cunningham; Jason Flannick; Stacey B Gabriel; David M Altshuler; Peter S Macdonald; Matthias Heinig; Anne M Keogh; Christopher S Hayward; Nicholas R Banner; Dudley J Pennell; Declan P O'Regan; Tan Ru San; Antonio de Marvao; Timothy J W Dawes; Ankur Gulati; Emma J Birks; Magdi H Yacoub; Michael Radke; Michael Gotthardt; James G Wilson; Christopher J O'Donnell; Sanjay K Prasad; Paul J R Barton; Diane Fatkin; Norbert Hubner; Jonathan G Seidman; Christine E Seidman; Stuart A Cook Journal: Sci Transl Med Date: 2015-01-14 Impact factor: 17.956
Authors: Oyediran Akinrinade; Laura Ollila; Sanna Vattulainen; Jonna Tallila; Massimiliano Gentile; Pertteli Salmenperä; Hannele Koillinen; Maija Kaartinen; Markku S Nieminen; Samuel Myllykangas; Tero-Pekka Alastalo; Juha W Koskenvuo; Tiina Heliö Journal: Eur Heart J Date: 2015-06-17 Impact factor: 29.983
Authors: Daniel S Herman; Lien Lam; Matthew R G Taylor; Libin Wang; Polakit Teekakirikul; Danos Christodoulou; Lauren Conner; Steven R DePalma; Barbara McDonough; Elizabeth Sparks; Debbie Lin Teodorescu; Allison L Cirino; Nicholas R Banner; Dudley J Pennell; Sharon Graw; Marco Merlo; Andrea Di Lenarda; Gianfranco Sinagra; J Martijn Bos; Michael J Ackerman; Richard N Mitchell; Charles E Murry; Neal K Lakdawala; Carolyn Y Ho; Paul J R Barton; Stuart A Cook; Luisa Mestroni; J G Seidman; Christine E Seidman Journal: N Engl J Med Date: 2012-02-16 Impact factor: 91.245
Authors: James P Pirruccello; Alexander Bick; Mark Chaffin; Krishna G Aragam; Seung Hoan Choi; Steven A Lubitz; Carolyn Y Ho; Kenney Ng; Anthony Philippakis; Patrick T Ellinor; Sekar Kathiresan; Amit V Khera Journal: J Am Coll Cardiol Date: 2020-03-17 Impact factor: 24.094
Authors: Eric D Carruth; Wilson Young; Dominik Beer; Cynthia A James; Hugh Calkins; Linyuan Jing; Sushravya Raghunath; Dustin N Hartzel; Joseph B Leader; H Lester Kirchner; Diane T Smelser; David J Carey; Melissa A Kelly; Amy C Sturm; Amro Alsaid; Brandon K Fornwalt; Christopher M Haggerty Journal: Circ Genom Precis Med Date: 2019-10-22
Authors: Anthony M Gacita; Lisa Dellefave-Castillo; Patrick G T Page; David Y Barefield; J Andrew Wasserstrom; Megan J Puckelwartz; Marcelo A Nobrega; Elizabeth M McNally Journal: Circ Heart Fail Date: 2020-09-30 Impact factor: 8.790
Authors: Rahul Goli; Jian Li; Jeff Brandimarto; Lisa D Levine; Valerie Riis; Quentin McAfee; Steven DePalma; Alireza Haghighi; J G Seidman; Christine E Seidman; Daniel Jacoby; George Macones; Daniel P Judge; Sarosh Rana; Kenneth B Margulies; Thomas P Cappola; Rami Alharethi; Julie Damp; Eileen Hsich; Uri Elkayam; Richard Sheppard; Jeffrey D Alexis; John Boehmer; Chizuko Kamiya; Finn Gustafsson; Peter Damm; Anne S Ersbøll; Sorel Goland; Denise Hilfiker-Kleiner; Dennis M McNamara; Zolt Arany Journal: Circulation Date: 2021-04-20 Impact factor: 29.690
Authors: Patrick S Connell; Amy M Berkman; BriAnna M Souder; Elisa J Pirozzi; Julia J Lovin; Jill A Rosenfeld; Pengfei Liu; Hari Tunuguntla; Hugh D Allen; Susan W Denfield; Jeffrey J Kim; Andrew P Landstrom Journal: Circ Genom Precis Med Date: 2020-11-23